Upakaar is live now for Order.

Chexid

Chexid Capsule, with the generic name Lansoprazole, is a proton pump inhibitor (PPI) manufactured by Aristo Pharmaceuticals Ltd. It’s available in Nepal.

8.35

Ask about product

Description

Chexid Capsule

Chexid Capsule, with the generic name Lansoprazole, is a proton pump inhibitor (PPI) manufactured by Aristo Pharmaceuticals Ltd. It’s available in Nepal.

Uses (Indications)

Chexid Capsule is used to treat conditions caused by excessive stomach acid, including:

  • Peptic ulcers (in the stomach or duodenum)
  • H. pylori infection (in combination therapy)
  • Gastro-oesophageal reflux disease (GERD)
  • Hypersecretory conditions (like Zollinger-Ellison syndrome)
  • Acid-related dyspepsia (indigestion)
  • NSAID-induced ulcers (ulcers caused by non-steroidal anti-inflammatory drugs)
  • Erosive oesophagitis (inflammation and erosion of the esophagus due to acid reflux)

How it Works (Mechanism of Action)

Lansoprazole, a substituted benzimidazole, is a proton pump inhibitor (PPI). It works by blocking the final step of acid secretion in the stomach’s parietal cells, specifically by inhibiting the H+/K+ ATPase enzyme system. This reduces both basal (resting) and stimulated acid production.

Dosage Information

Administration: Chexid Capsule should be taken on an empty stomach, preferably before meals.

Adults:

  • Peptic Ulcer:
    • Duodenal Ulcer: 30 mg once daily in the morning for up to 4 weeks.
    • Gastric Ulcer: 30 mg once daily in the morning for up to 8 weeks.
    • Maintenance: 15 mg once daily.
  • Zollinger-Ellison Syndrome: Initially, 60 mg once daily in the morning. Doses greater than 120 mg daily should be divided into two doses. Adjust as needed.
  • Acid-Related Dyspepsia: 15-30 mg once daily in the morning for 2-4 weeks.
  • Gastro-oesophageal Reflux Disease (GERD): 15-30 mg once daily in the morning for 4-8 weeks.
    • Maintenance: 15-30 mg once daily, adjusted based on response.
  • Prophylaxis of NSAID-Induced Ulcers: 15-30 mg once daily in the morning.
  • H. pylori Infection (1-week Triple Therapy): 30 mg twice daily, combined with:
    • Clarithromycin 500 mg twice daily and Amoxicillin 1 g twice daily, OR
    • Clarithromycin 250 mg twice daily and Metronidazole 400 mg twice daily.
  • Erosive Oesophagitis: 30 mg once daily in the morning for up to 8 weeks. An additional 8 weeks may be given if not healed.
    • Maintenance: 15 mg once daily.
  • NSAID-Associated Ulceration: 30 mg once daily in the morning for 4-8 weeks.
  • Elderly: No dosage adjustment is typically needed.
  • Hepatic Impairment: For severe hepatic impairment, the maximum dose is 30 mg per day.
  • Renal Impairment: No dosage adjustment is needed.

Children:

  • Gastro-oesophageal Reflux Disease (GERD) & Erosive Oesophagitis:
    • 1-11 years:
      • Less than 30 kg: 15 mg once daily in the morning for up to 12 weeks.
      • More than 30 kg: 30 mg once daily in the morning for up to 12 weeks.
      • Doses may be increased up to 30 mg twice daily if symptoms persist after 2 or more weeks of treatment.
    • 12-17 years: 15 mg once daily for up to 8 weeks (for GERD) or 30 mg once daily for up to 8 weeks (for erosive oesophagitis).

Important Considerations

Do Not Use If You Have (Contraindications):

  • Known hypersensitivity to Lansoprazole or any of its components.

Use with Caution If You Have (Precautions):

  • Hepatic impairment.
  • A gastric malignancy should be ruled out before starting treatment, as symptoms of gastric malignancy may be masked by Lansoprazole.
  • Pregnancy and Lactation: Not known whether Lansoprazole is distributed into breast milk; breastfeeding is generally not recommended.

Potential Drug Interactions

  • Increased Risk of Hypomagnesemia: With diuretics and digoxin.
  • Decreased Plasma Concentration of Other Drugs: Erlotinib, dasatinib, lapatinib.
  • Decreased Bioavailability: Itraconazole and ketoconazole.
  • Increased Plasma Concentration: Cilostazol and methotrexate.
  • Reduced Bioavailability: Antacids and sucralfate may reduce the absorption of Chexid; take Chexid at least 30 minutes before antacids or sucralfate.

Potentially Fatal Interactions:

  • May significantly decrease serum levels and pharmacological effects of rilpivirine and atazanavir.

Possible Side Effects (Adverse Effects)

Common (1-10%):

  • Headache (3-7%)
  • Diarrhea (1-5%)
  • Constipation (1-5%)
  • Nausea (1-3%)
  • Abdominal pain (1-3%)

Less Common (<1%):

  • Anxiety
  • Angina
  • Palpitations
  • Syncope
  • Edema
  • Anorexia
  • Dry mouth
  • Tenesmus
  • Flatulence
  • Melena (dark, tarry stools)
  • Myalgia (muscle pain)
  • Tinnitus (ringing in the ears)
  • Allergic reactions

Disclaimer: This information about Chexid Capsule is for general knowledge and informational purposes only and does not constitute medical advice. It is not intended for diagnosis, treatment, or to be a substitute for the professional judgment of a healthcare provider. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment

Additional information

form

Oral Tablets

Reviews

There are no reviews yet.

Be the first to review “Chexid”

Your email address will not be published. Required fields are marked *